Artak Labadzhyan is an Endocrinology/Metabolic physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 31 publications with 345 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8700 Beverly Blvd
West Hollywood, CA 900481804
Telephone
310-423-2830Registry record last updated 3 Dec 2018.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chiasma, Inc.Program year20215 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
44.4%l-Thyroxine34.4%Levothyroxine Sodium66%Synthroid34%Part D≥58 patientsThyroid Hormone Synthesis Inhibitor4.6%Methimazole100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
39.1%GLP-1 receptor agonist17.3%Ozempic74%Mounjaro19%Trulicity7%Part D<11 patientsBiguanide (metformin)8.9%Metformin Hcl74%Metformin Hcl Er26%Part D<11 patients+ 4 more classes in this area
Sensory organs
7.2%Corticosteroid7.2%Hydrocortisone100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of acromegaly subtypes on survival: results from a large multicenter cohort
Journal of the Endocrine Society
2026 - MON-082 Identification and Management of Ectopic ACTH Syndrome Secondary to Olfactory Neuroblastoma
Journal of the Endocrine Society
2025 - 8524 Pituitary Hormone Dysregulation In Symptomatic Long COVID: A Multi-Center Observational Study
Journal of the Endocrine Society
2024 - 9191 Real-world Biochemical And Symptoms Outcomes With Oral Octreotide: Management Of Acromegaly (MACRO) Registry Experience
Journal of the Endocrine Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”